Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

A Realistic Way to Save Rainforests

01.10.2003


U of U biologists Phyllis Coley and Tom Kursar spent five years working in Panama to conserve rainforests and promote economic development by stimulating a native industry aimed at finding new medicines in rainforest plants.
Credit: Tom Kursar & Phyllis Coley


Plants develop chemical defenses to survive attackes by insects such as these grasshoppers. Those chemicals sometimes can be developed into medicines to combat human diseases.
Credit: Robin Foster, Field Museum, Chicago


Exploit Plant Defenses, Build Local Drug Discovery Industry

Misty-eyed idealism alone will not save Earth’s dwindling tropical rainforests. But a five-year, $3 million study in Panama indicates rainforests can be protected if the pharmaceutical industry establishes Third World laboratories and hires local researchers to look for new medicines extracted from plants that evolved defenses against insects.

“Until now, efforts to find drugs in the rainforest haven’t really led to rainforest conservation,” says Tom Kursar, an associate professor of biology at the University of Utah, who led the study with his wife, biology Professor Phyllis Coley. “But we have developed a novel approach that provides a direct link between looking for drugs and promoting conservation and economic development in biodiversity-rich countries.”



Coley adds: “Rainforests are disappearing at a terrifying rate. Searching for drugs in the rainforests of developing countries might be one solution. In our research, not only are we finding potential pharmaceuticals, but we are contributing to conservation of the forests.”

The study was funded by $3 million in grants to Coley and colleagues through the Smithsonian Tropical Research Institute in Balboa, Panama, where they also hold appointments and spend a few months each year. The money came from the National Institutes of Health, National Science Foundation and U.S. Department of Agriculture. The results were published in October’s issue of the Ecological Society of America journal Frontiers in Ecology and the Environment. The report was written by Coley, Kursar and 13 other scientists, most from the University of Panama.

Trying to save rainforests via “bioprospecting” for potential new medicines is based on the idea that developing nations will work to conserve their rainforests if nondestructive industries such as bioprospecting, ecotourism and watershed protection provide greater economic benefits than logging and ranching.

But the concept has not been particularly effective because only a small fraction of plant extracts actually are developed into drugs, and when they are, it takes years for the nation with the rainforest to start earning royalties.

“The challenge, therefore, is to provide immediate and guaranteed benefits even if royalties are not forthcoming,” the biologists wrote. “A solution becomes apparent upon recognizing that the research and development pyramid underlying the successful development of a drug is based on many basic but essential discoveries, a tiny fraction of which result in a product.”

Worldwide drug company investment in research and development is estimated at $27 billion to $43 billion annually, and “about one-third of that is spent on research that could be carried out in developing countries,” including extraction of chemicals from rainforest plants, synthetic production of those chemicals for use as medicines, lab testing of the chemicals’ activity against disease, and testing in animals.

“If part of these huge investments by industry, governments of developed nations and nongovernmental organizations would be redirected toward bioprospecting research in the source country [the source of the plants], then biodiversity-rich countries would receive immediate and guaranteed benefits from the nondestructive use of their natural resources,” Coley, Kursar and their Panamanian colleague said in the study.

The pilot project in Panama demonstrates how that could work. The project produced benefits for Panama by establishing bioprospecting, chemical extraction and laboratory operations in the nation using local students as well as scientists who taught at local universities but who previously lacked funding to conduct research.

“By conducting all of the research in Panama, we circumvent the issue of uncertain royalties and provide immediate and lasting benefits in the form of training, employment, technology transfer and infrastructure development,” the biologists wrote.

During the past five years, the project established six laboratories in Panama and employed local citizens: 10 senior scientists, 57 paid research assistants and 12 student volunteers. Twenty Panamanian students earned bachelors degrees in the process, a dozen earned or worked on master’s degrees, and one started work on a doctorate.

The Smithsonian Tropical Research Institute and Panamanian scientists recently obtained a provisional patent for three alkaloid chemicals extracted from local plants. Tests by Panamanian scientists Luz Romero and Luis Cubilla-Rios showed the chemicals were active against the parasite that causes leishmaniasis, a potentially fatal disease caused by parasites transmitted by sand fly bites. The chemicals now are being tested in Panama on mice to determine if they are safe, and tests are just starting to determine if they are effective against leishmaniasis in animals.

Kursar says the number of plant extracts that become drugs is less important than having scientists from Panama find and develop potential drugs.

“You do the work in the host country and you are creating jobs,” Coley says. “The next step is for the country to recognize those jobs depend on the intact rainforest.”

Why should drug companies set up labs and hire staff in developing nations?

“They collaborate all the time with academic scientists and small biotech firms in the developed world,” says Coley. “If the capability exists in developing nations, such research could be done there, perhaps at a lower cost.”

In a commentary accompanying the study, Jeffrey McNeeley, chief scientist of the World Conservation Union, noted some bioprospecting efforts have been called “biopiracy,” such as when a drug company made $200 million in profits selling cancer drugs developed from Madagascar’s rosy periwinkle while that country “got nothing.”

McNeeley praised the Panama project led by Coley and Kursar as “an excellent first step” that “shows how to conduct more of the value-added bioprospecting research in the source country, and build the technical capacity of local people while doing so.”

The new study also showed how potential drugs can be found more effectively by focusing on how plants make chemicals to defend themselves against insects.

“Despite the many drugs obtained from plants in the past, success rates could be greatly improved by incorporating ecological knowledge,” the researchers wrote.

The scientists collected leaves throughout Panama’s protected wild lands, prepared extracts and tested the extracts on breast, lung and nervous system cancer cells; on the AIDS virus; and on organisms that cause three tropical diseases: malaria, leishmaniasis, and Chagas’ disease, a parasitic infection that kills 50,000 people each year. Plant extracts were considered highly active if they killed or inhibited the growth of the cancerous or infected cells without killing other cells.

The study found:
-- Chemical activity was much greater in young leaves than in older leaves because young leaves lack the toughness that older leaves use as a defense against insects. So young leaves are more likely to contain potential medicines.
-- Young leaves contain more active chemicals than older leaves, even from the same plant. The researchers tested 18 woody plant species, and found 10 of the species contained toxic chemicals called alkaloids that were present only in young leaves, not old leaves. Only three species had alkaloids in old leaves and not young leaves.
-- Plants that live in the shade are more likely to contain active chemicals than sun-loving plants. It takes longer for a shade-tolerant plant to grow new leaves to replace those eaten by insects, so the shade-tolerant plants develop stronger chemical defenses than plants that live in sunlight and can replace leaves more quickly.

The drug-hunting principles tested by Coley and Kursar in Panama were developed during years of earlier work in Africa, Southeast Asia and Panama, “and therefore should be applicable to tropical forests worldwide,” they wrote.

Phyllis Coley | University of Utah
Further information:
http://www.utah.edu/unews/releases/03/sep/medplant.html

More articles from Ecology, The Environment and Conservation:

nachricht Conservationists are sounding the alarm: parrots much more threatened than assumed
15.09.2017 | Justus-Liebig-Universität Gießen

nachricht A new indicator for marine ecosystem changes: the diatom/dinoflagellate index
21.08.2017 | Leibniz-Institut für Ostseeforschung Warnemünde

All articles from Ecology, The Environment and Conservation >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: The pyrenoid is a carbon-fixing liquid droplet

Plants and algae use the enzyme Rubisco to fix carbon dioxide, removing it from the atmosphere and converting it into biomass. Algae have figured out a way to increase the efficiency of carbon fixation. They gather most of their Rubisco into a ball-shaped microcompartment called the pyrenoid, which they flood with a high local concentration of carbon dioxide. A team of scientists at Princeton University, the Carnegie Institution for Science, Stanford University and the Max Plank Institute of Biochemistry have unravelled the mysteries of how the pyrenoid is assembled. These insights can help to engineer crops that remove more carbon dioxide from the atmosphere while producing more food.

A warming planet

Im Focus: Highly precise wiring in the Cerebral Cortex

Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.

The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Penn first in world to treat patient with new radiation technology

22.09.2017 | Medical Engineering

Calculating quietness

22.09.2017 | Physics and Astronomy

Hope to discover sure signs of life on Mars? New research says look for the element vanadium

22.09.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>